Rocket


Overview
Financials
News + Filings

 
 

TScan Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues20.69.4
            Revenue growth117.9% 
Cost of goods sold40.118.9
Gross profit-19.5-9.4
            Gross margin-94.7%-100.0%
General and administrative6.74.8
EBIT-26.2-14.2
            EBIT margin-127.5%-150.5%
Pre-tax income-26.1-13.7
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-26.1-13.7
            Net margin-127.0%-144.7%
 
Diluted EPS($3.48)($4.33)
Shares outstanding (diluted)7.53.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy